Moderní technologie a způsob jejich využívání pro optimalizaci léčby diabetu 1. i 2. typu v praxi

Chlup, Rudolf; Krystyník, Ondřej; Nádvorníková, Michaela; Zálešáková, Hana; Ďurajková, Emília; Poljaková, Iveta; Kudlová, Pavla; Bártek, Josef; Zapletalová, Jana; Procházka, Vlastimil

dc.title	Moderní technologie a způsob jejich využívání pro optimalizaci léčby diabetu 1. i 2. typu v praxi	cs
dc.title	Ten-point glycaemic profile: A flexible indicator of therapeutic efficacy and dawn phenomenon in persons with type 1 or type 2 diabetes mellitus	en
dc.contributor.author	Chlup, Rudolf
dc.contributor.author	Krystyník, Ondřej
dc.contributor.author	Nádvorníková, Michaela
dc.contributor.author	Zálešáková, Hana
dc.contributor.author	Ďurajková, Emília
dc.contributor.author	Poljaková, Iveta
dc.contributor.author	Kudlová, Pavla
dc.contributor.author	Bártek, Josef
dc.contributor.author	Zapletalová, Jana
dc.contributor.author	Procházka, Vlastimil
dc.relation.ispartof	Klinická farmakologie a farmacie
dc.identifier.issn	1212-7973 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued	2014
utb.relation.volume	28
utb.relation.issue	2
dc.citation.spage	72
dc.citation.epage	79
dc.type	article
dc.language.iso	en
dc.language.iso	cs
dc.publisher	SOLEN s.r.o.
dc.relation.uri	http://www.klinickafarmakologie.cz/en/artkey/far-201402-0009.php
dc.subject	Carelink	en
dc.subject	Dawn phenomenon	en
dc.subject	Diabass 5	en
dc.subject	Diabetes mellitus	en
dc.subject	Glucometer	en
dc.subject	Glycaemic profile	en
dc.subject	Insulin pumps	en
dc.subject	Selfmonitoring	en
dc.subject	Therapeutic education	en
dc.description.abstract	This overview has summarized the authors' experience with intensive selfmonitoring including an evaluation of glucometers' reliability. A ten-point glycaemic profile and continuous monitoring are flexible indicators of therapeutic effectiveness and the dawn phenomenon in persons with type 1 or type 2 diabetes mellitus. A personal glucometer, selfmonitoring and education are now becoming prerequisites for successful intensive insulin treatment particularly when using the insulin pump. These modern methods should be implemented into practice. The following types of glucometers have been subsequently tested at the authors' workplaces: One Touch (Lifescan, GB), Optium (Medisense/Abbott, GB), Card (Medisense/Abbott, GB), Advance (Hypoguard, GB), Linus (Agamatrix, USA), Contourlink (Bayer, BRD) a CALLA (Wellion, Austria). Accuracy andrepeatability of results oéf tested glucometers allow their implementation into practice.	en
utb.faculty	Faculty of Humanities
dc.identifier.uri	http://hdl.handle.net/10563/1007869
utb.identifier.obdid	43872813
utb.identifier.scopus	2-s2.0-84904968642
utb.source	j-scopus
dc.date.accessioned	2018-04-23T15:01:49Z
dc.date.available	2018-04-23T15:01:49Z
utb.contributor.internalauthor	Kudlová, Pavla
utb.fulltext.affiliation	Rudolf Chlup1, 2, 3, Ondřej Krystyník1, Michaela Nádvorníková3, Hana Zálešáková3, Emilia Ďurajková3, Iveta Poljaková2, Pavla Kudlová4, Josef Bartek5, Jana Zapletalová6, Vlastimil Procházka1 1 II. interní klinika Lékařské fakulty Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc 2 Ústav fyziologie Lékařské fakulty Univerzity Palackého v Olomouci 3 Odborný léčebný ústav neurologicko-geriatrický Moravský Beroun 4 Ústav zdravotnických věd Fakulty humanitních studií Univerzity Tomáše Bati ve Zlíně 5 Ústav lékařské chemie a biochemie Lékařské fakulty Univerzity Palackého v Olomouci 6 Ústav lékařské biofyziky Lékařské fakulty Univerzity Palackého v Olomouci doc. MUDr. Rudolf Chlup, CSc. Ústav fyziologie LFUP v Olomouci a II. interní klinika FNOL I. P. Pavlova 6, 779 00 Olomouc [email protected]
utb.fulltext.dates	Článek přijat redakcí: 18. 11. 2013 Článek přijat k publikaci: 12. 3. 2014
utb.fulltext.references	1. Poljakova I, Elsikova E, Chlup R, Kalabus S, Hasala P, Zapletalova J. Glucose sensing module – Is it time to integrate it into real-time perioperative monitoring? An observational pilot study with subcutaneous sensors. Biomedical Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013; 157(4): 346–357. 2. Česká diabetologická společnost: Doporučený postup péče o nemocné s diabetes mellitus 1. typu. Diabetes, endokrinologie, metabolismus, výživa 2012; 1: 8–12. 3. Česká diabetologická společnost: Doporučený postup péče o nemocné s diabetes mellitus 2. typu. Diabetes, endokrinologie, metabolismus, výživa 2012; 1: 13–19. 4. Česká diabetologická společnost: Doporučený postup péče o nemocné s prediabetem. Diabetes, endokrinologie, metabolismus, výživa 2012; 1: 20–22. 5. Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, Salzsieder E. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Research and Clinical Practice 2007; 77: 420–426. 6. Kohnert KD, Augstein P, Zander E, Heinke P, Peterson K, Freyse EJ, Hovorka R, Salzsieder E. Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 2009; 32(6): 1058–1062. 7. Miller KM, Beck RW, Bergenstal RM, Goland RS, Haller MJ, McGill JB, Rodriguez H, Simmons JH, Hirsch IB. T1D Exchange Clinic Network: Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1C levels in T1D Exchange Clinic Registry participants. Diabetes Care 2013 February 1 [Epub ahead of print]. 8. Langova K, Pribylova H, Kajabova M, Luza J. Assessment of haemoglobin a1c evolution using two statistical approaches (survival analysis and linear regression) in persons with diabetes mellitus. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009; 153(2): 137–144. 9. Peterson K, Zapletalova J, Kudlova P, Matuskova V, Bartek J, Novotny D, Chlup R. Benefi ts of three-month continuous glucose monitoring for persons with diabetes using insulin pumps and sensors. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009; 153(1): 47–52. 10. Mazze R, Lucido D, Langer O, Hartmann K, Rodbard D. Ambulatory glucose profi le: representation of verifi ed self-monitored blood glucose data. Diabetes Care 1987; 10: 111–117. 11. Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfi n G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM. Recommendations for standardizing glucose reporting and analysis to optimizme clinical decision making in diabetes: the Ambulatory Glucose Profi le (AGP). Diabetes Technol Ther 2013; 15: 198–211. 12. Garg SK, Hirsch IB. Self-Monitoring of Blood Glucose An Overview. Diabetes Technology & Therapeutics 2013; 15(Suppl 1): S3–S12. 13. Hirsch IB, Amiel SA, Blumer IR, Bode BW, Edelman SV, Seley JJ, Verderese CA, Kilpatrick ES. Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther 2012; 11: 973–983. 14. Berger M, Jörgens V, Chlup R. Léčba inzulinem v každodenním životě. Ed. 1. Victoria Publishing, Praha, 1995. 15. Bibergeil H Ed. Diabetes mellitus – ein Nachschlagewerk für die diabetologische Praxis. Edition 3, 1988, VEB Gustav Fischer Verlag Jena. 16. Bruns W, Fiedler H, Altman B, Lundershausen R, Menzel R, Worms F, Kriegstein E. Insulintherapie bei Typ 2 Diabetes Pathophysiologisch begründete Therapie mitz insulin unter besonderer Berücksichtigung der Insulinresistenz und des Inkretineff ektes. 2. Aufl age-Bremen. Germany, UNIMED Verlag AG, 2010. 17. Chlup R, Gazárek F, Krikal Z, Flasarová B. Diabetes mellitus a tehotenstvi [Diabetes mellitus and gravidity (author‘s transl)][Article in Czech]. Cesk Gynekol. 1976; 41(2): 113–115. PMID: 1268961. 18. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. Brit Med J 2011; 343: d3805. 19. Chlup R, Možíšová L. Léčba diabetiků pomocí inzulinové pumpy – teorie a praxe. Diabetologie Metabolismus Endokrinologie Výživa 2000; 3(1): 3–17. 20. Chlup R, Janů K, Menzel R, Bruns W, Venháčová J. Léčba diabetu pomocí ručního dávkovače inzulinu MADI. Ed. Univerzita Palackého v Olomouci, 1985. 21. Chlup R, Janu K, Venhacova J, Bartek J. Six models of a new insulin pen (MADI): Description and fi rst clinical trial. Practical Diabetes International 1995; 12(1): 32–35. 22. Bruns W. Insulin therapy in obese patients with type 2 diabetes [Insulintherapie des adiposen typ-2-diabetes]. Diabetes und Stoff wechsel 1999; 8(SUPPL 6): 26–31. 23. Bruns, W, Jutzi E, Fischer U, Bombor H, Woltanski KP, Jahr D, Wodrig W, Albrecht G. Circadian variations in insulin concentrations and blood glucose in non-diabetics as well as insulin requirements in insulin-dependent diabetics. [Uber tagesrhythmische Veränderungen der Insulinkonzentrationen und der Plasmaglukose bei Nichtdiabetikern sowie des Insulinbedarfs bei insulinpfl ichtigen Diabetikern.] Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete 1981; 36(5): 258–260. 24. Chlup R, Menzel R, Keilacker H, Heinke P, Jutzi E. Night injections of regular insulin improve diabetes control in C-peptide negative patients. Diabetologia 1997; 40(Suppl): 1292–1292 (Abstract). 25. Chlup R, Vaverkova H, Bartek J. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. I. Eff ects on blood glucose control. Exp Clin Endocrinol Diabetes 1997; 105(Suppl 2): 70–73. 26. Chlup R, Zapletalová J, Seckar P, Chlupová L, Táncosová S, Reznícková M. Benefi ts of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 Diabetes treated by means of an insulin pump. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004; 148(1): 27–32. 27. Chlup R, Zapletalová J, Seckar P, Malá E, Doubravová B, Táncosová S, Chlupová L, Pukowietz L, Zatloukal P. Benefi ts of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus. Diabetes Technol Ther. 2007; 9(3): 223–231. 28. Chlup R, Zapletalová J, Sečkař P, Chlupová L, Táncosová S, Řezníčková M. Benefits of insulin aspart vs phosphate-buffered human regular insulin in persons with type 1 diabetes treated by means of an insulin pump. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004; 148(1): 27–32. 29. Chlup R, Navrátilová L, Řehořová J, Vaverková H, Venháčová J, Bartek J, Ficker L, Slezáková L. Programová léčba diabetu. Ed. 1, 1996, Galén, Praha. 30. Chlup R, Doubravova B, Bartek J, Zapletalova J, Krystynik O, Prochazka V. Eff ective Assessment of Diabetes Control Using Personal Glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA). Disease Markers 2013; 35(6): 895–905. 31. Kudlová P, Chlup R. Selfmonitoring u osob s diabetem. Interní Medicina pro Praxi 2009; 11(Suppl B): B66–B71. 32. Chlup R, Beránková I, Boudová E, Ďurajková E, Faltýnková J, Fišarová S, Gajdošová M, Grecmanová M, Holá J, Holešinská P, Hrubá V, Kmoníčková A, Konštacká L, Pevná Z, Řehořová J, Strnadová J, Šefl ová L. Doporučení pro léčbu inzulinem u dospělých diabetiků při hospitalizaci – návrh standardu. Klin Farmakol Farm 2003; 17(1): 34–42. 33. ISO 15197 In Vitro Diagnostic Test Systems-Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197: 2003(E). Geneva: International Standards Organization, 2003. 34. ISO/DIS 15197 In Vitro Diagnostic Test Systems-Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/DIS 15197: 2013. Geneva: International Standards Organization, 2013. 35. Thorpe GH. Assessing the quality of publications evaluating the accuracy of blood glucose monitoring systems. Diabetes Technology & Therapeutics. 2013; 15(3): 253–259. 36. Freckmann G, Schmid C, Baumstark A, Pleus S, Link M, Haug C. System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 197. J Diabetes Sci Technol 2012; 6(5): 1060–1075. 37. Chlup R, Bartek J, Malá E, Doubravová B, Pukowietz L, Zatloukal P, Chlupová L, Zapletalová J. Uživatelská studie o správnosti a přesnosti měření glukometrů Advance, Card a Optium (User oriented study on accuracy and precision of glucometer systems Advance, Card and Optium). Klin Bioch Metabol 2004; 12(3): 171–178. 38. Chlup R, Bartek J, Zapletalová J, Sečkař P, Pukowietz L, Řezníčková M, Havrdová M, Rulfová L. Výsledky měření P-glukosy na glukometrech Advance a Optium v laboratorních podmínkách (Results of P-glucose estimations by means of glucometers Advance and Optium under laboratory conditions). Klin Bioch Met 2004; 12(3): 160–170. 39. Chlup R, Payne M, Zapletalová J, Komenda S, Doubravová B, Reznícková M, Chlupová L, Seckar P. Results of selfmonitoring on glucometer systems Advance and Optium in daily routine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005; 149(1): 127–139. 40. Chlup R, Doubravova B, Peterson K, Zapletalova J, Bartek J. Wavesense technology glucometer Linus for routine self-monitoring and clinical practice. Acta Diabetol 2011; 48(1): 35–40. 41. Chlup R, Doubravova B, Zapletalova J, Peterson K, Bartek J. Plasma glucose concentrations on new glucometer CALLA strongly correlate with laboratory analyser COBAS INTEGRA 400 PLUS under various clinical conditions. Diabetes Technol Ther 2011; 13(2): 213–214 (Abstract). 42. Chlup R, Doubravova B, Zapletalova J, Langova K, Bartek J. Glucometers (CALLA) appear to be more convenient means for routine P-glucose monitoring in patients admitted to hospital than a laboratory analyzer (COBAS INTEGRA). Diabetes Technol Ther 2011; 13(2): 214–215 (Abstract). 43. Mlčák P, Chlup R, Boudová E, Bartek J, Zapletalová J. Assessment of glucose concentrations in intersticial fl uid in non-diabetic subjects with regard to detection of the dawn phenomenon – Pilot study. [Vývoj koncentrace glukosy v intersticiální tekutině u nediabetiků s ohledem na detekci fenoménu svítání – Pilotní studie]. Klin Bioch Metabol 2003; 11(1): 44–49. 44. Mlcak P, Fialová J, Trnková K, Chlup R. A continuous glucose monitoring system (CGMS) – a promising aproach for improving metabolic control in persons with type 1 diabetes mellitus treated by insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc, Czech Repub. 2004; 148: 33–38. 45. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009; 11: 717–723. 46. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R, Schierloh U, Sulli N, Bolinder J. the SWITCH Study Group: The use and effi cacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155–3162. 47. Damiano ER, El-Khatip FH, Zheng H, Nathan DD, Russell SJ. A comparative eff ectiveness analysis of three continuous glucose monitors. Diabetes Care 2013; 36: 251–259. 48. Jadviscokova T, Fajkusova Z, Pallayova M, Luza J, Kuzmina G. Occurence of adverse events due to continuous glucose monitoring. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007; 151(2): 263–266. 49. Chlup R, Mlčák P, Boudová E, Fialová J, Barker J. Continuous glucose monitoring in interstitial fl uid – Initial experience [Kontinuální monitorování koncentrace glukosy v intersticiální tekutině – naše první zkušenosti]. Klin Bioch Metabol 2003; 11(1): 37–43. 50. Chlup R, Jelenova D, Kudlova P, Chlupova K, Bartek J, Zapletalova J, Langova K, Chlupova L. Continuous glucose monitoring – a novel approach to the determination of the glycaemic index of foods (DEGIF 1). Exp Clin Endocrinol Diabetes 2006; 114: 68–74. 51. Liebl A, Henrichs HR, Heinemann L, Freckmann G, Biermann E, Thomas A. Continuous Glucose Monitoring Working Group of the Working Group Diabetes Technology of the German Diabetes Association. Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol. 2013; 7(2): 500–519. PubMed PMID: 23567009. 52. Peterson K, Chlup R, Zapletalova J, Kohnert KD, Kudlova P, Bartek J, Nakladalova M, Doubravova B, Seckar P. Infl uence of oral antidiabetic drugs on hyperglycemic response to foods in persons with type 2 diabetes mellitus as assessed by continuous glucose monitoring system: a pilot study. J Diabetes Sci Technol 2010; 4(4): 983–992. 53. Bruttomesso D, Costa S, Baritussio A. Continuous subcutaneous insulin infusion (CSII) 30 years later: Still the best option for insulin therapy (Review). Diabetes/Metabolism Research and Reviews 2009; 25(2): 99–111. 54. Cohen O, Körner A, Chlup R, Zoupas CS, Ragozin AK, Wudi K, Bartaskova D, Pappas A, Niederland T, Taybani Z, Barák L, Vazeou A. Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: Prospective results from a community and academic practice patient registry. Journal of Diabetes Science and Technology 2009; 3(4): 804–811. 55. Jankovec Z, Hahn M, Grunder S, Lacigova S, Cechurova D, Krcma M, Zourek M, Haladova I, Rusavy Z. Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy.Diabetes Research and Clinical Practice 2010; 87(2): 219–223. 56. Jankovec Z, Krcma M, Gruberova J, Komorousova J, Tomesova J, Zourek M, Rusavy Z. Infl uence of physical activity on metabolic state within a 3h interruption of continuous subcutaneous insulin infusion in patients with type 1 diabetes. Diabetes Technology and Therapeutics 2011; 13(12): 1234–1239. 57. Jankovec Z. Options of treatment with insulin pumps (Review) [Možnosti léčby inzulinovými pumpami]. Interni Medicina pro Praxi 2012; 14(3): 116–118. 58. Lippaiova N, Pallayova M, Kuzmina G, Peterson K, Fajkosova L, Luza J. Safety of new algorithms for premeal insulin boluses in high glycaemic index meals in persons with type 1 diabetes mellitus using insulin pumps. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152(1): 73–77
utb.fulltext.sponsorship	-
utb.scopus.affiliation	II. interní klinika, Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc, Czech Republic; Ústav fyziologie, Univerzity Palackého v Olomouci, Czech Republic; Odbornylecebný ústav neurologicko-geriatrický Moravský Beroun, Czech Republic; Ústav zdravotnických věd, Univerzity Tomáše Bati ve Zlíně, Czech Republic; Ústav lékařské chemie a biochemie, Univerzity Palackého v Olomouci, Czech Republic; Ústav lékařské biofyziky, Univerzity Palackého v Olomouci, Czech Republic
utb.fulltext.projects	-